As more regenerative medicine research moves toward clinical trials, it’s a perfect time to be asking not just ‘what can we achieve?’, but also ‘what can we afford?’Crossing the valley of death between regenerative medicine research and clinical approval requires rethinking how we evaluate and fund the clinical trial process. (Stock photo)The promise of regenerative medicine — new treatments and cures for many devastating and costly diseases — will soon be within our grasp. Globally, there are now more than 700…

Continue reading

Dr. Karun Singh, an investigator at the Stem Cell and Cancer Research Institute at McMaster University, hopes to lead the way towards a new treatment for Autism Spectrum DisorderBuilding a puzzle without the reference image on the box cover is no easy task. You might find a few pieces that go together by matching colours or connecting fragments of an image, or string together a stretch of the puzzle’s edge, but in either case you won’t…

Continue reading